Interleukin-4: molecular structure and biochemical characteristics, biological function, and receptor expression
Ohara, J.
Year in Immunology 5: 126-159
1989
ISSN/ISBN: 0256-2308 PMID: 2652925 Document Number: 334125
Document emailed within 1 workday
Related Documents
Kawashima, I.; Ohsumi, J.; Miyadai, K.; Takiguchi, Y. 1992: Function, molecular structure and gene expression of interleukin-11 (IL-11/AGIF) Nihon Rinsho. Japanese Journal of Clinical Medicine 50(8): 1833-1839Sonoda, Y. 1992: Function, molecular structure and gene expression regulation of interleukin 9 (IL-9) Nihon Rinsho. Japanese Journal of Clinical Medicine 50(8): 1821-1826
Tikhonov, I.I.; Fomin, I.K.; Doroshenko, T.M.; Chalyĭ, I.V.; Voĭtenok, N.N. 1996: Expression of cDNA for human interleukin-8 type one receptor in BALB 3T3 fibroblasts and characteristics of products of expression Molekuliarnaia Biologiia 30(5): 1014-1021
Defeo-Jones, D.; Tai, J.Y.; Oliff, A. 1991: Molecular and biochemical approaches to structure--function analysis of transforming growth factor alpha Methods in Enzymology 198: 191-200
Asano, S. 1992: Function, molecular structure and gene expression of granulocyte colony-stimulating factor Nihon Rinsho. Japanese Journal of Clinical Medicine 50(8): 1854-1860
Kanakura, Y.; Sugahara, H.; Mitsui, H.; Ikeda, H.; Furitsu, T.; Yagura, H.; Kitayama, H.; Kanayama, Y.; Matsuzawa, Y. 1993: Functional expression of interleukin 2 receptor in a human factor-dependent megakaryoblastic leukemia cell line: evidence that granulocyte-macrophage colony-stimulating factor inhibits interleukin 2 binding to its receptor Cancer Research 53(3): 675-680
Leers-sucheta, S.; Stormshak, F. 1991: Molecular characteristics of the LH receptor and its role in regulating corpus luteum function Advances in Contraceptive Delivery Systems: Cds 7(2): 101-127
Sun, R.X.; Gennaro, C.; Rocco, S.; Gu, Z.J.; Klein, B. 1997: Interleukin-6 receptor antagonists inhibit interleukin-11 biological activity European Cytokine Network 8(1): 51-56
Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Wang, Q.; Zhan, F.-x.; Shan, N.-n.; Hou, M.; Yang, X.-j.; Lu, N.; Wang, H.-c.; Zhang, X.-l.; Ji, X.-b.; Ji, C.-y. 2010: Expression of interleukin-18 and interleukin-18 receptor alpha chain of the peripheral white blood cells in immune thrombocytopenia Zhonghua Nei Ke Za Zhi 49(4): 316-319
Zhang, Q.-p.; Xie, L.-k.; Zhang, L.-j.; Tan, J.-q. 2005: Apoptosis in human germinal centre B cells by means of CC chemokine receptor 3 expression induced by interleukin-2 and interleukin-4 Chinese Medical Journal 118(8): 665-670
Takii, T.; Hayashi, H.; Marunouchi, T.; Onozaki, K. 1994: Interleukin-1 down-regulates type I interleukin 1 receptor mRNA expression in a human fibroblast cell line TIG-1 in the absence of prostaglandin E2 synthesis Lymphokine and Cytokine Research 13(3): 213-219
Shinkura, H.; Imazeki, I.; Yamazaki, M.; Oda, Y.; Kotoh, M.; Mihara, M. 1998: In vivo blocking effects of a humanized antibody to human interleukin-6 receptor on interleukin-6 function in primates Anticancer Research 18(2a): 1217-1221
Sun, A.; Chu, C.T.; Liu, B.Y.; Wang, J.T.; Leu, J.S.; Chiang, C.P. 2000: Expression of interleukin-2 receptor by activated peripheral blood lymphocytes upregulated by the plasma level of interleukin-2 in patients with recurrent aphthous ulcers Proceedings of the National Science Council Republic of China. Part B Life Sciences 24(3): 116-122
Chen, Z.; Colon, I.; Ortiz, N.; Callister, M.; Dong, G.; Pegram, M.Y.; Arosarena, O.; Strome, S.; Nicholson, J.C.; Van Waes, C. 1998: Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines Cancer Research 58(16): 3668-3676
Sims, J.E.; Smith, D.E. 2003: Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type Ii and interleukin-1 receptor accessory protein European Cytokine Network 14(2): 77-81
Zurawski, S.M.; Zurawski, G. 1989: Mouse interleukin-2 structure-function studies: substitutions in the first alpha-helix can specifically inactivate p70 receptor binding and mutations in the fifth alpha-helix can specifically inactivate p55 receptor binding EMBO Journal 8(9): 2583-2590
Pizzolo, G. 1991: The soluble interleukin-2 receptor as a new biological marker in diseases Allergologia et Immunopathologia 19(4): 176-180
Wustrow, T.P. 1991: Interactions and biological mechanisms of action of molecular signal peptides. II. Interleukin 2 (IL-2) Hno 39(9): 323-331
Yu, Z.Y. 1994: Advances in the biochemical and molecular biological study on angiotensinogen Zhonghua Yi Xue Za Zhi 74(9): 574-576